Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice

References

• van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179–83
   PubMed Web of Science ®Google Scholar
• Teh GC, Sahabuddin RM, Lim TC, et al. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during prostate health awareness campaign. Med J Malaysia 2001;56:186–95
   Google Scholar
• Man-Kay L, Lester G, Patron N, et al. An Asian multinational prospective observational registry of patient with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJUI 2007;101:197–202
   Google Scholar
• Azhar AH, Mohd Nor GR, Ashraf MD, Zainal M. A survey on LUTs among patients with BPH in HUSM. Mal J Med Sci 2007;14:67–71
   Google Scholar
• Koji Y, Hiroki O, Kentaro I, et al. Nocturia and benign prostatic hyperplasia. Urology 2003;61:786–90
   Google Scholar
• Christopher HCK, Praveen S, Goh EH, et al. Prevalence and awareness of LUTs among males in the outpatient clinics of UKM medical center. Med Health 2011;6:98–106
   Google Scholar
• Bosch R, Weiss JP. The prevalence and causes of nocturia. J Urol 2010;184:440–6
   PubMed Web of Science ®Google Scholar
• Theodore MJ, Richard WS, Patricia P, et al. Evaluating potentially modifiable risk factors for prevalent and incident nocturiain older adults. J Am Getriatr Soc 2005;53:1011–16
   Google Scholar
• Haruo N, Kaijun N, Atsushi H, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol 2010;184:1413–18
   Google Scholar
• Varant K, Mary PF, Steven AK, et al. Association of nocturia and mortality. Results from the third national health and nutrition examination survey. J Urol 2011;185:571–7
   Google Scholar
• Bing MH, Lars AM, Jennum P, et al. Nocturia and associated morbidity in a Danish population of men and women aged 60–80 years. BJUI 2008;102:808–15
   Google Scholar
• Kathryn LB, Theodore MJ, Patricia SG, et al. Prevalence and correlates of nocturia in community dwelling older adults. J Am Geriatr Soc 2010;58:861–6
   Google Scholar
• Tikkinen KAO, Auvinen A, Huhtala H, Teuvo LJT. Nocturia and obesity: a population based study in Finland. Am J Epidemiol 2006;163:1003–11
   PubMed Web of Science ®Google Scholar
• Mary PF, Heather JL, Carol LL, John BM. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007;177:1385–9
   Google Scholar
• Jin MH, Moon DG. Practical management of nocturia in urology. Ind J Urol 2008;24:289–94
   PubMedGoogle Scholar
• Deborah JL, Amy EK, Debra JJ, et al. Nocturia is associated with an increased risk of coronary heart disease and death. BJUI 2012;110:848–53
   Google Scholar
• Yoong HF, BalaSundram M, Aida Z. Prevalence of nocturia in patients with benign prostatic hyperplasia. Med J Malaysia 2005;60:294–6
   PubMedGoogle Scholar
• Marriappan P, Turner KJ, Sothilingam S, et al. Nocturia, nocturia indices and variables from frequency volume charts are significantly different in Asian and Caucasian men with LUTs: a prospective comparison study. BJUI 2007;100:332–6
   Google Scholar
• Schneider T, Marshall-Kehrel D, Hanisch JU, Michel MC. Do gender, age or lifestyle factors affect response to antimuscarinic treatment. Int J Clin Pract 2010;64:1287–93
   PubMed Web of Science ®Google Scholar
• Hakkinen JT, Hakama M, Shiri R, et al. Incidence of nocturia in 50–80 year old Finnish Men. J Urol 2006;176:2541–5
   PubMed Web of Science ®Google Scholar
• Kim MK, Zhao C, Kim SD, et al. Relationship of sex hormones and nocturia in lower urinary tract symptoms induced by benign prostatic hyperplasia. Aging Male 2012;15:90–5
   PubMed Web of Science ®Google Scholar
• Weiss JP, Blavias JG, Jones M, et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007;178:548–51
   PubMed Web of Science ®Google Scholar
• Michel MC, Schneider T, Krege S, Goepel M. Do gender or age affect the efficacy and safety of tolterodine? J Urol 2002;168:1027–31
   PubMed Web of Science ®Google Scholar
• Thoedore MJ, Pamela KB, John WK, et al. The effect of doxazosin, finasteride and combination therapy on nocturia and men with benign prostatic hyperplasia. J Urol 2007;178:2045–51
   Google Scholar
• Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and tamsulosin for treatment of men with LUTs and OAB. JAMA 2006;296:2319
   PubMed Web of Science ®Google Scholar
• Debruyne FM, Witjes WP, Fitzpatrick J, et al. The international terazosin trial: a multicenter study of the long term efficacy and safety of terazosin in the treatment of BPH. Eur Urol 1996;30:369--76
   PubMed Web of Science ®Google Scholar
• Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finateride or both in BPH. Veterans Affairs Cooperative Studies BPH Study Group. N Engl J Med 1996;335:533--40
   PubMed Web of Science ®Google Scholar
• Chapple CR, Martinez-Garcia R, Selvaggi L, et al. A comparison of the efficacy and tolerability of solefinacin succinate and extended release tolterodine at treating overactive bladder syndrome: result of the STAR trial. Eur Urol 2005;48:464–70
   PubMed Web of Science ®Google Scholar
• Yokoyama O, Yamaguchi O, Kakizaki H, et al. Efficacy of solefinacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol 2011;186:170–4
   PubMed Web of Science ®Google Scholar
• Kaplan S, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005;174:2273–5
   PubMed Web of Science ®Google Scholar
• Lose G, Mattiasson A, Walter S, et al. Clinical experience with desmopressin for long term treatment of nocturia. J Urol 2004;172:1021–5
   PubMed Web of Science ®Google Scholar
• Matthias O, Bachmann A, Aurélien D, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64:118–40
   Google Scholar
• Rembratt A, Norgaard JP, Andersson KE. Desmopressin in elderly patients with nocturia: short term safety and effects on urine output, sleep and voiding patterns. BJUI 2003;91:642–6
   PubMed Web of Science ®Google Scholar
• Ceylan C, Ceylan T, Doluoglu OG, et al. Comparing effectiveness of intra nasal desmopressin and doxazosin in me with nocturia: a pilot randomized clinical trial. Urol J 2013;10:993–8
   Web of Science ®Google Scholar
• Tien H, Jurij L. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Sci World J 2013. [Epub ahead of print]. doi:org/10.1155/2013/878564
   Google Scholar
• Foley DJ, Vitiello MV, Bliwise DL, et al. Frequent napping is associated with excessive daytime sleepiness, depression, pain and nocturia in older adults: findings from the national sleep foundation ‘2003 Sleep in America’ poll. Am J Geriatr Psychiatry 2007;15:344–50
   PubMed Web of Science ®Google Scholar
• Parsons JK, Sarma AV, McVary K, Weis JT. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 2009;182:S27–31
   PubMed Web of Science ®Google Scholar
• Mei HH, Aih FC, Wang CC, Kuo HC. Prevalance and risk factors for nocturia in middle aged and elderly people from public health centers in Taiwan. Int Braz J Urol 2012;38:818–24
   Google Scholar
• Camille PV, Anssi A, Rufus C, et al. Impact of obesity on urinary storage symptoms: results from the FINNO study. J Urol 2012;189:1377–82
   Google Scholar
• World Health Organization. Western Pacific Region International Association for the study of Obesity. The Asia pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Limited; 2000
   Google Scholar
• Lee SH, Kim JC, Lee JY, et al. Effects of obesity on lower urinary tract symptoms in Korean BPH patients. Asian J Androl 2009;11:663–8
   Web of Science ®Google Scholar
• Rohrmann S, Smit E, Giovannucci E, Platz EA. Association of obesity with lower urinary tract symptoms and non-cancer prostate surgery in the Third National health and nutrition examination survey. Am J Epidemiol 2004;159:390–7
   PubMed Web of Science ®Google Scholar
• Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJUI 2002;90:649–54
   Google Scholar
• Asplund R, Aberg HE. Nocturia in relation to body mass index, smoking and some other life style factors in women. Climacteric 2004;7:267–73
   PubMed Web of Science ®Google Scholar
• Shiri R, Hakama M, Hakkinen J, et al. The effects of lifestyle factors on the incidence of nocturia. J Urol 2008;180:2059–62
   Google Scholar
• Chyou PH, Nomura AM, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet and other lifestyle factors in relation to obstructive uropathy. Prostate 1993;22:253–64
   Google Scholar